newsfilter
← Latest News
GlobeNewswire·

MannKind to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

  • MannKind Corporation (NASDAQ: MNKD) announced CEO Michael Castagna, PharmD will present business updates at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on Thursday, February 26, 2026, at 11:20 a.m. ET.
  • A live webcast link & a recorded version available for approximately 90 days will be hosted on the company's investor relations website at https://investors.mannkindcorp.com/events-and-presentations.
  • MannKind is a biopharmaceutical company focused on cardiometabolic & orphan lung diseases, developing drug-device combination therapies for diabetes, pulmonary hypertension, & fluid overload in heart failure & chronic kidney disease.
  • Investor Relations inquiries can be directed to Kate Miranda at (617) 921-5461 or ir@mnkd.com.
  • Media Relations inquiries can be directed to Christie Iacangelo at (818) 292-3500 or media@mnkd.com.